Hidden brain damage in young sickle cell patients: new study aims to find answers
NCT ID NCT04808778
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how common strokes and silent brain injuries are in young adults (ages 16-25) with sickle cell anemia, especially in Nigeria where the disease is widespread. Researchers will use brain scans and blood tests to check for damage and identify risk factors like high blood pressure or diabetes. The goal is to find better ways to prevent strokes in this high-risk group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hydroxyurea therapy (moderate dose of 20 mg/kg/day)
What this could lead to
If successful, this could identify key risk factors for stroke in young adults with sickle cell anemia, paving the way for targeted prevention strategies in low-resource settings.
What could go wrong
This is an observational study with a small sample size (250 participants) in one region of Nigeria, so results may not apply broadly. The study does not test a new treatment, so direct patient benefits are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aminu Kano Teaching Hospital
Kano, Nigeria
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-9000, United States